All Stories

  1. Integrated stability and metabolomic investigation of new Rifampicin and Isoniazid co-loaded liposome against tuberculosis
  2. A review on intervention of AI in pharmaceutical sector: Revolutionizing drug discovery and manufacturing
  3. Unleashing potential of methotrexate-amino acid methyl ester-loaded lipidic nanocapsules as magic bullets against resistant breast cancer
  4. Pharmaceutical medicine advertising regulations in Australia, Japan, the United States, and India: An overview
  5. Biowaiver based on biopharmaceutics classification system: Considerations and requirements
  6. Interactions between multifunctional pharmaceutical excipients and efflux pump for optimal drug transport and bioavailability: An overview
  7. Biopharmaceutical advancement of efonidipine hydrochloride ethanolate through amorphous solid dispersion of a Parteck SLC mesoporous silica polymer
  8. Artificial intelligence in pharmaceutical regulatory affairs
  9. Common chemistry, manufacturing, and control deficiencies in abbreviated new drug applications assessed by the US Food and drug administration: Hurdle to access cost-effective medicines
  10. Investigation of a biopolymer-based pH-responsive and sustained release raft-gel-forming tablet of famotidine: In-vitro, ex-vivo, bioavailability and anti-ulcer evaluation in New Zealand albino rabbit
  11. Evaluation of curcumin-loaded chitosan nanoparticles for wound healing activity
  12. Bioanalytical method development and Validation for determination of efonidipine hydrochloride ethanolate in rat plasma by high-performance liquid chromatography: applications for pharmacokinetic study
  13. Microwave-assisted grafting of acrylamide on a natural xylan gum for controlled drug delivery
  14. Investigation of a Quantitative Bioanalytical HPLC Method for the Assessment of Famotidine in Pre-clinical Samples: Application for Pharmacokinetic Studies
  15. Artificial intelligence (AI) in drug product designing, development, and manufacturing
  16. Synthesis and characterization of chitosan nanoparticles decorated with folate and loaded with dasatinib for targeting folate receptors in cancer cells
  17. Interactive Teaching in Higher Education for Effective Knowledge Dissemination and Improved Student Participation
  18. Effect of polymers and process parameters in augmenting the compactability and dissolution behaviour of oxcarbazepine spherical agglomerates
  19. COMPARATIVE PHARMACEUTICAL EVALUATION OF VARIABLE RETAIL PRICED MEDICINES CONTAINING BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS-II OR CLASS-IV DRUGS
  20. International Regulations for Bioequivalence Approval of Locally Acting Orally Inhaled Drug Products
  21. Development of lipoprotein-drug conjugates for targeted drug delivery
  22. Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview
  23. An Overview of the Drug Registration Requirements for Export to Tanzania, Nepal, and Cambodia
  24. Global Pediatric Regulations: An Overview
  25. QSPR Modeling of Biopharmaceutical Properties of Hydroxypropyl Methylcellulose (Cellulose Ethers) Tablets Based on Its Degree of Polymerization
  26. Global Pediatric Regulations: An Overview
  27. Quantitative Structure–Property Relationship Approach in Formulation Development: an Overview
  28. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design
  29. Bioanalytical method development and validation for estimation of formulated sustained release tablet of Nateglinide in Rabbit plasma.
  30. An Overview of the Drug Registration Requirements for Export to Tanzania, Nepal, and Cambodia
  31. Characterization of pharmaceutical nanocarriers: in vitro and in vivo studies
  32. Development of Stability-Indicating HPLC Method and Accelerated Stability Studies for Osmotic and Pulsatile Tablet Formulations of Clopidogrel Bisulfate
  33. Development of controlled release cellulose-pellets based multicore tablets
  34. Quantitative structure–property relationship modeling for the prediction of hydrophilic drug entrapment in liposomes for lung targeted delivery
  35. Computational Modeling of Polymeric Physicochemical Properties for Formulation Development of a Drug Containing Basic Functionality
  36. Design and development of potent and selective factor IXa inhibitors
  37. Statistical significance of polymeric physicochemical properties in the development of formulations containing a drug from neutral class
  38. Quantitative structure property relationship modeling of excipient properties for prediction of formulation characteristics
  39. Experimental and chemoinformatics evaluation of some physicochemical properties of excipients influencing release kinetics of the acidic drug ibuprofen
  40. Polymers influencing transportability profile of drug
  41. Investigation of tablettability and drug release properties of ethyl cellulose
  42. Glass transition temperature: Basics and application in pharmaceutical sector